Caxton Associates (UK)’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,203
Closed -$415K 892
2025
Q4
$415K Sell
4,203
-2,478
-37% -$240K 0.01% 547
2025
Q3
$567K Sell
6,681
-4,753
-42% -$376K 0.01% 436
2025
Q2
$779K Sell
11,434
-16,202
-59% -$1.03M 0.02% 355
2025
Q1
$1.67M Buy
+27,636
New +$1.93M 0.06% 202

Other funds holding INCY

Caxton Associates (UK)'s INCY Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Incyte (INCY) in Q1 2026, closing a stake of 4,203 shares — an estimated $415K sold.

Caxton Associates (UK) first reported a position in INCY in Q1 2025 and held it in 4 quarters. The position peaked at $1.67M in Q1 2025. 815 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Incyte position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 4,203 Incyte shares in Q1 2026, an estimated $415K.
  • Caxton Associates (UK) first reported a position in Incyte in Q1 2025 and held it in 4 quarters.
  • Caxton Associates (UK)'s Incyte position peaked at $1.67M in Q1 2025.
  • 815 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.